10/03/2017
Miramar, Fla. – October 2, 2017 – ImmunoSite Technologies, LLC, a leading global provider of contract R&D services, upgrades their dual ISO certifications from American Global Standard to the new standards as another step in their commitment to quality and customer service. ImmunoSite Technologies Automation Services are concentrated on fulfilling the special needs of life […]

05/22/2014
Tags:
Biomarker,
Clinical Trials,
Drug DevelopmentBiomarker data from Astra Zeneca demonstrates that biomarkers enhance success in every aspect (safety, dosing, efficacy, patient selection) of every state of the drug development process.

02/10/2014
ImmunoSite Technologies, LLC receives the 2013 Innovative Business award

02/02/2014
02/01/2014. ImmunoSite Technologies was certified as a National MBE, Minority Business Enterprise, by the Southern Florida Minority Supplier Development Council as defined by the U.S. National Minority Supplier Development Council. The NMSDC was chartered in 1972 and is one of the country’s leading corporate membership organizations to advance business opportunities for certified business enterprises of all […]

03/03/2013
Tags:
Assay Automation,
ImmunoSite Technologies,
Particle Testing,
R&D Support,
ServicesPress Release, February 28, 2013 ImmunoSite Technologies, LLC (IST), a provider of automation, design and customization of complex biological assays to biotechnology and pharmaceutical industries worldwide, announced its relocation to a newly expanded facility at 2831 Corporate Way in Miramar. With the expansion, the company will be retaining its current employees, making a capital investment […]

01/19/2013
Tags:
Assay Automation,
ImmunoSite Technologies,
IST Partnerships,
ServicesExecutives, Engineers, and Scientists from ImmunoSite Technologies attended the Annual 2013 SLAS meeting in Orlando, Florida and brought back some of the latest technologies to integrate into new automated solutions for biological assay automation that will enhance their client’s productivity even more! Call IST to discuss your automation needs at (888) 770-4478 Share this:

10/18/2012
Tags:
BioFlorida,
ImmunoSite Technologies,
IST PartnershipsCell Culture Course helps Floridians enter, remain and advance in the workforce Fort Lauderdale, Fla. – October 18, 2011 – ImmunoSite Technologies (IST), LLC, a leading provider of immune monitoring services, has helped to develop a Cell Culture Workshop that is offered at the Employ Florida Banner Center for Life Sciences, based at Palm Beach […]

04/03/2011
Tags:
Coulter Principle,
dynamic light scattering,
IST Partnerships,
laser diffraction,
Particle Testing,
pharmaceutical characterization,
PSD,
Services,
zeta potential
Leading provider of particle testing services now receives referrals of customers seeking particle characterization services from Beckman Coulter, Inc. Fort Lauderdale, Fla. – April 3, 2011 – ImmunoSite Technologies, LLC, a leading provider of immune monitoring services, is now receiving direct customer referrals for particle testing services from Beckman Coulter, Inc. as part of a […]
